What is Afsaneh Alavi's NPI number?

Afsaneh Alavi's National Provider Identifier (NPI) is 1083211023, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Afsaneh Alavi's specialty?

Afsaneh Alavi is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Afsaneh Alavi located?

Afsaneh Alavi's practice location on file with NPPES is 200 1st St Sw, Rochester, MN 55905-0002.

What is Afsaneh Alavi's phone number?

The practice phone number listed in the NPPES registry for Afsaneh Alavi is (507) 538-0601.

Does Afsaneh Alavi accept Medicare?

Afsaneh Alavi is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Afsaneh Alavi's NPI active?

Yes — Afsaneh Alavi's NPI (1083211023) is active in the NPPES registry as of the last update on 2020-12-17.

IndividualActiveAccepts Medicare

Afsaneh Alavi, MD

NPI 1083211023 · Dermatology Physician · Rochester, MN

Afsaneh Alavi, MD is a Dermatology Physician provider in Rochester, MN (NPI 1083211023).

Provider details

NPI number: 1083211023
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Female
Sole proprietor: Yes
License: 1014 (MN)

Practice location

200 1st St Sw

Rochester, MN 55905-0002

Phone: (507) 538-0601

Fax: (507) 284-2072

Approximate (ZIP-level) locationGet directions

More MN providers

Mailing address

200 1st St Sw

Rochester, MN 55905-0001

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 1014 (MN)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(56/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
6 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
1,398 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	463	$2
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	188	$65
Destruction of Precancer Skin Growth, 1 Growth17000	180	$52
Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More99212	141	$35
Destruction of Skin Growth, 1-14 Growths17110	71	$69
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 7 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Triamcinolone Acetonide	65	39
Ketoconazole	55	26
Methotrexate Sodiumbrand: Methotrexate	25	—
Hydrocortisone	17	12
Fluocinonide	14	—
Metronidazole	11	—
Sulfamethoxazole/Trimethoprimbrand: Sulfamethoxazole-Trimethoprim	11	—

Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$20,001 across 14 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2020-10-02
Last updated: 2020-12-17
Certified: 2020-12-17

Frequently asked questions

What is Afsaneh Alavi's NPI number?: Afsaneh Alavi's National Provider Identifier (NPI) is 1083211023, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Afsaneh Alavi's specialty?: Afsaneh Alavi is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Afsaneh Alavi located?: Afsaneh Alavi's practice location on file with NPPES is 200 1st St Sw, Rochester, MN 55905-0002.
What is Afsaneh Alavi's phone number?: The practice phone number listed in the NPPES registry for Afsaneh Alavi is (507) 538-0601.
Does Afsaneh Alavi accept Medicare?: Afsaneh Alavi is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Afsaneh Alavi's NPI active?: Yes — Afsaneh Alavi's NPI (1083211023) is active in the NPPES registry as of the last update on 2020-12-17.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	463	$2
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	188	$65
Destruction of Precancer Skin Growth, 1 Growth17000	180	$52
Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More99212	141	$35
Destruction of Skin Growth, 1-14 Growths17110	71	$69
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 7 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Triamcinolone Acetonide	65	39
Ketoconazole	55	26
Methotrexate Sodiumbrand: Methotrexate	25	—
Hydrocortisone	17	12
Fluocinonide	14	—
Metronidazole	11	—
Sulfamethoxazole/Trimethoprimbrand: Sulfamethoxazole-Trimethoprim	11	—

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$20,001 across 14 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments